Form 8-K - Current report:
SEC Accession No. 0001193125-24-274871
Filing Date
2024-12-11
Accepted
2024-12-11 07:46:30
Documents
20
Period of Report
2024-12-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d875134d8k.htm   iXBRL 8-K 39010
2 EX-1.1 d875134dex11.htm EX-1.1 251533
3 EX-1.2 d875134dex12.htm EX-1.2 40818
4 EX-1.3 d875134dex13.htm EX-1.3 42049
5 EX-5.1 d875134dex51.htm EX-5.1 12474
6 EX-99.1 d875134dex991.htm EX-99.1 11977
10 GRAPHIC g875134g1211090755224.jpg GRAPHIC 3089
11 GRAPHIC g875134g35s84.jpg GRAPHIC 33083
  Complete submission text file 0001193125-24-274871.txt   669241

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA ibrx-20241210.xsd EX-101.SCH 2515
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ibrx-20241210_lab.xml EX-101.LAB 17204
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ibrx-20241210_pre.xml EX-101.PRE 10792
22 EXTRACTED XBRL INSTANCE DOCUMENT d875134d8k_htm.xml XML 3590
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (844) 696-5235
ImmunityBio, Inc. (Filer) CIK: 0001326110 (see all company filings)

IRS No.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37507 | Film No.: 241540153
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)